Search

Author/Creator Dottore, Mara

1. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. Issue 3 (2nd April 2016)

Authors:
Panousis, Con; Dhagat, Urmi; Edwards, Kirsten M.; Rayzman, Veronika; Hardy, Matthew P.; Braley, Hal; Gauvreau, Gail M.; Hercus, Timothy R.; Smith, Steven; Sehmi, Roma; McMillan, Laura; Dottore, Mara; McClure, Barbara J.; Fabri, Louis J.; Vairo, Gino; Lopez, Angel F; Parker, Michael W.; Nash, Andr...
Journal:
MAbs
Issue:
Volume 8:Issue 3(2016)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody. (14th February 2022)

Authors:
Tvorogov, Denis; Thompson‐Peach, Chloe A L; Foßelteder, Johannes; Dottore, Mara; Stomski, Frank; Onnesha, Suraiya A; Lim, Kelly; Moretti, Paul A B; Pitson, Stuart M; Ross, David M; Reinisch, Andreas; Thomas, Daniel; Lopez, Angel F
Journal:
EMBO reports
Issue:
Volume 23:Number 4(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search